IOM Calls on FDA to Improve Safety of Approved Drugs

The Institute of Medicine has proposed the FDA create a central management plan for every new drug to strengthen oversight of drugs over the entire life cycle.

Read the full report in Becker's Hospital Review on the IOM report.